Dynavax Technologies Corp. (NASDAQ: DVAX) on Monday, soared 2.23% from the previous trading day, before settling in for the closing price of $11.20. Within the past 52 weeks, DVAX’s price has moved between $9.74 and $15.15.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 239.63%. The company achieved an average annual earnings per share of 489.28%. With a float of $130.26 million, this company’s outstanding shares have now reached $131.04 million.
Considering the fact that the conglomerate employs 408 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 82.03%, operating margin of -5.56%, and the pretax margin is 7.43%.
Dynavax Technologies Corp. (DVAX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Dynavax Technologies Corp. is 0.60%, while institutional ownership is 101.48%. The most recent insider transaction that took place on May 31 ’24, was worth 43,127. In this transaction Director of this company sold 3,615 shares at a rate of $11.93, taking the stock ownership to the 36,905 shares. Before that another transaction happened on Mar 01 ’24, when Company’s Chief Accounting Officer sold 20,526 for $12.78, making the entire transaction worth $262,322. This insider now owns 0 shares in total.
Dynavax Technologies Corp. (DVAX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 489.28% per share during the next fiscal year.
Dynavax Technologies Corp. (NASDAQ: DVAX) Trading Performance Indicators
Dynavax Technologies Corp. (DVAX) is currently performing well based on its current performance indicators. A quick ratio of 13.18 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.01. Likewise, its price to free cash flow for the trailing twelve months is 42.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.11, a number that is poised to hit 0.12 in the next quarter and is forecasted to reach 0.37 in one year’s time.
Technical Analysis of Dynavax Technologies Corp. (DVAX)
Compared to the last year’s volume of 2.13 million, its volume of 1.51 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 90.26%. Additionally, its Average True Range was 0.40.
During the past 100 days, Dynavax Technologies Corp.’s (DVAX) raw stochastic average was set at 54.81%, which indicates a significant decrease from 97.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.91% in the past 14 days, which was higher than the 33.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.13, while its 200-day Moving Average is $12.35. Nevertheless, the first resistance level for the watch stands at $11.60 in the near term. At $11.76, the stock is likely to face the second major resistance level. The third major resistance level sits at $12.04. If the price goes on to break the first support level at $11.17, it is likely to go to the next support level at $10.89. Now, if the price goes above the second support level, the third support stands at $10.74.
Dynavax Technologies Corp. (NASDAQ: DVAX) Key Stats
Market capitalization of the company is 1.50 billion based on 130,892K outstanding shares. Right now, sales total 232,280 K and income totals -6,390 K. The company made 73,800 K in profit during its latest quarter, and 11,390 K in sales during its previous quarter.
